RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Clinical trials for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA explained in plain language.
Never miss a new study
Get alerted when new RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA trials appear
Sign up with your email to follow new studies for RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy shows promise for rare 'Butterfly Skin' wounds
Disease control OngoingThis study tests a gene therapy called FCX-007 to help heal wounds in people with recessive dystrophic epidermolysis bullosa (RDEB), a rare skin condition that causes severe blistering. The treatment uses the patient's own skin cells, modified to produce a missing protein, and is…
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE3 • Sponsor: Castle Creek Biosciences, LLC. • Aim: Disease control
Last updated May 26, 2026 10:47 UTC
-
New eye drops aim to soothe painful eye injuries in rare skin disease
Symptom relief OngoingThis study tests whether ELK-003 eye drops can safely ease eye symptoms in people with junctional or dystrophic epidermolysis bullosa (EB), a rare genetic condition causing fragile skin and frequent eye injuries. About 20 participants will first be observed, then use the drops 6 …
Matched conditions: RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
Phase: PHASE1 • Sponsor: Fundación DEBRA Chile, Niños Piel de Cristal • Aim: Symptom relief
Last updated May 26, 2026 10:53 UTC